Prof. Sander Woutersen of the Van ‘t Hoff Institute for Molecular Sciences (UvA) has been awarded a Demonstrator Grant of 160,000 euros by the Dutch Research Council NWO (Domain Applied and Engineering Sciences). Together with his colleague and Veni-fellow Dr Giulia Giubertoni he will be developing a structure- and size-sensitive chemical probe.
In their project IR-DOSY, Woutersen and Giubertoni envision a new device that can determine molecular structure and size simultaneously in a cost-effective, non-invasive and simple manner. Its working is based on the combination of microfluidic technology with infrared spectroscopy.
In earlier research, the researchers have already validated this concept in a pilot. Together with the Technology Centre, IXA, and Demonstrator Lab Science Park, Woutersen and Giubertoni will now further develop it into a device that can be used by researchers from different disciplines in any laboratory as an analytical or diagnostic tool.
Image: UvA Technology Centre – Design of the IR-DOSY apparatus
See also
Working paper at ChemRxiv: Infrared Diffusion-Ordered Spectroscopy Reveals Molecular Size and Structure
Demonstrator is one of NWO’s valorisation instruments. It is aimed at researchers that want to further develop their results to make them attractive to the market. Six projects were awarded funding in the 2022 round of Demonstrator. With funding from this program, researchers manufacture a product or service in the form of a demonstration model. This serves as a showcase to enable a market introduction of that technology.
PULSE Sport, a start-up from the Demonstrator Lab, has reached a significant milestone by winning the prestigious 14th Dutch Sports Innovation Award. The company’s flagship product, a cutting-edge athlete management system, integrates advanced software and artificial intelligence to revolutionize athlete health and performance monitoring. About the Innovation PULSE Sport’s athlete management system provides a holistic […]
NewsAmsterdam researchers have secured Biotech Booster funding for a total of six projects, that include a promising cancer treatment, a new diagnostic method for Alzheimer’s Disease, an implant helping blindness, lab innovation in biotechnology, and a nutritional intervention for mental health. The researchers will develop a solid business case for their innovations in the time […]
NewsVU-AMS is on a mission to revolutionize how we understand and manage stress-related health issues. Now an official VU spin-off, there are big plans for clinical applications. Founder of VU AMS Martin Gevonden explains: “We offer researchers autonomic biomarkers that are valid, reliable and easy to use, without getting under the skin.” After thriving in […]
News